This activity is being hosted on behalf of the Global Multiple Sclerosis Academy. For more information, visit the site: www.GlobalMultipleSclerosisAcademy.org.
This interactive module, led by Dr. Gavin Giovannoni, will review the current and future treatment options for treating and managing MS patients based on the mechanism of action. This education will also explore various approached to managing MS patients by drugs that module the immune system.
As of August 2017, Cladribine was approved in Europe for the treatment of highly active relapsing multiple sclerosis (RMS). All studies presented in this education are still accurate. To learn more about this approval, click here.